Viewing Study NCT05052567


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2025-12-25 @ 10:32 PM
Study NCT ID: NCT05052567
Status: COMPLETED
Last Update Posted: 2024-09-04
First Post: 2021-08-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module